Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239510 · ClinicalTrials.gov registry record · NA
Efficacy of Linaclotide to Senna for CIC
A NA study, sponsored by TriHealth.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02239510: Clinical Trial NA study, sponsored by TriHealth.
NCT02239510 is a NA study that was terminated before completion, run by TriHealth. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02239510, a NA study, was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
In this prospective, randomized, double blind study, the aim is to determine the efficacy of Linaclotide in relation to Senna in relieving the symptoms of chronic idiopathic constipation (CIC). Patients with CIC, (age 18 - 70) will be enrolled in the study and randomized to Senna or Linaclotide. Patients will be asked to complete questionnaires during the study and will be followed for 12 weeks. Main outcomes include number of daily bowel movements and measures from surveys regarding bowel habits, relief, and satisfaction.
Primary Outcome
Change from before to after in number of weekly bowel movements
Interventions
- DRUG Senna
- DRUG Linzess
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-06 |
| Phase | NA |
Why NCT02239510 stopped before completion
NCT02239510 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Senna is the first listed.
NCT02239510 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02239510 about?
NCT02239510 is a clinical study titled "Efficacy of Linaclotide to Senna for CIC". In this prospective, randomized, double blind study, the aim is to determine the efficacy of Linaclotide in relation to Senna in relieving the symptoms of chronic idiopathic constipation (CIC). Patients with CIC, (age 18 - 70) will be enrolled in the study and randomized to Senna or Linaclotide. Pat...
What is the current status of trial NCT02239510?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2014-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02239510?
The interventions under investigation include: Senna (DRUG), Linzess (DRUG).
Who is sponsoring clinical trial NCT02239510?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02239510's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia